Back to
Capital Research Global Investors
TEVAShowing 0 of 19 quarters
Position history for
Capital Research Global Investors's holdings in TEVA PHARMACEUTICAL INDS LTD
No. Capital Research Global Investors exited its TEVA (Teva Pharmaceutical Industries) position in Q2 2023. Its Q1 2023 13F listed 82,644,367 shares worth $731.4M. Capital Research Global Investors already held TEVA in its Q4 2018 13F, the earliest on record, and held it in 18 quarterly 13F filings.
Current Value
-
Current Shares
-
Total Value Change
$0
Total Shares Change
0
No position history available for this security.
Other major holders of TEVA: BlackRock, Inc., FMR LLC, Phoenix Financial Ltd.